P1: SBT
0521779407-03 CUNY1086/Karliner 0 521 77940 7 June 7, 2007 19:6
100 Alpha-1-Antitrypsin
Alpha-1-Antitrypsin..................................
ERIC LEONG, MD, FRCPC
history & physical
Symptoms and Signs
■Neonates: jaundice at 1–2 months of age; hepatomegaly
■Infants: may present with symptoms and signs of chronic liver
failure; fewer patients present with acute liver failure; a few present
with cholestasis
■Children & adolescents: may present with liver failure
■Adults: may present with symptoms and signs of chronic hepatitis,
cirrhosis, portal hypertension, HCC, or emphysema
tests
Basic Tests: Blood
■Liver biochemistry: ALT, AST, and GGT elevated in half of infants
with homozygous deficiency & in up to 10% of young adults
■Serum alpha-1-AT concentration: often low; can be misleading due
to elevation in setting of inflammation
Specific Diagnostic Test
■Serum alpha-1-AT phenotype: PiMM phenotype present in 90–95%
of population associated with normal serum alpha-1-AT level; PiZZ
phenotype associated with severe alpha-1-AT deficiency and poten-
tial development of pulmonary emphysema or liver disease; PiMZ
and PiSZ associated with intermediate deficiency
Imaging
■Abdominal sonogram or CT scan: nondiagnostic
■Chest roentgenogram: emphysematous changes
Liver Biopsy
■Accumulation of eosinophilic, periodic acid-Schiff-positive, dias-
tase-resistant globules in endoplasmic reticulum of periportal hep-
atocytes
differential diagnosis
■Viral hepatitis, biliary atresia in neonates & infants, cystic fibrosis,
autoimmune hepatitis, Wilson’s disease, Gaucher’s disease, glycogen
storage diseases